Arvinas (ARVN) News Today $7.67 -0.15 (-1.92%) Closing price 06/11/2025 04:00 PM EasternExtended Trading$7.66 -0.01 (-0.20%) As of 04:04 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock ARVN Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 Time Period Cantor Fitzgerald Weighs in on Arvinas FY2026 EarningsJune 12 at 2:05 AM | americanbankingnews.comCantor Fitzgerald Comments on Arvinas FY2026 EarningsArvinas, Inc. (NASDAQ:ARVN - Free Report) - Cantor Fitzgerald issued their FY2026 earnings estimates for shares of Arvinas in a report released on Monday, June 9th. Cantor Fitzgerald analyst L. Watsek anticipates that the company will post earnings of ($1.84) per share for the year. The consensusJune 11 at 9:04 AM | marketbeat.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Arvinas, Inc. - ARVNJune 7, 2025 | prnewswire.comArvinas (NASDAQ:ARVN) Stock Price Up 8.7% - Still a Buy?Arvinas (NASDAQ:ARVN) Trading 8.7% Higher - Here's WhyJune 6, 2025 | marketbeat.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Arvinas, Inc. - ARVNJune 6, 2025 | globenewswire.comArvinas, Pfizer Seek FDA Approval of Vepdegestrant in Breast CancerJune 6, 2025 | marketwatch.comArvinas Announces Submission of New Drug Application to U.S. FDA for Vepdegestrant for Patients with ESR1-Mutated ER+/HER2- Advanced or Metastatic Breast CancerJune 6, 2025 | globenewswire.comWhat is Wedbush's Forecast for Arvinas FY2026 Earnings?June 6, 2025 | americanbankingnews.comQ2 Earnings Forecast for Arvinas Issued By Leerink PartnrsJune 6, 2025 | americanbankingnews.comArvinas to Present Preclinical Data for PROTAC BCL6 Degrader, ARV-393, at the 2025 European Hematology Association (EHA) Annual MeetingJune 5, 2025 | globenewswire.comWedbush Weighs in on Arvinas' FY2026 Earnings (NASDAQ:ARVN)Arvinas, Inc. (NASDAQ:ARVN - Free Report) - Stock analysts at Wedbush boosted their FY2026 EPS estimates for shares of Arvinas in a report released on Monday, June 2nd. Wedbush analyst R. Driscoll now anticipates that the company will post earnings of ($2.36) per share for the year, up from theirJune 5, 2025 | marketbeat.comLeerink Partnrs Estimates Arvinas' Q2 Earnings (NASDAQ:ARVN)Arvinas, Inc. (NASDAQ:ARVN - Free Report) - Investment analysts at Leerink Partnrs upped their Q2 2025 earnings per share (EPS) estimates for shares of Arvinas in a note issued to investors on Sunday, June 1st. Leerink Partnrs analyst A. Berens now expects that the company will earn $0.26 per shaJune 4, 2025 | marketbeat.comArvinas (NASDAQ:ARVN) Receives Market Perform Rating from Leerink PartnersJune 4, 2025 | americanbankingnews.comArvinas (NASDAQ:ARVN) Shares Gap Down - Here's WhyArvinas (NASDAQ:ARVN) Shares Gap Down - Here's What HappenedJune 3, 2025 | marketbeat.comArvinas (NASDAQ:ARVN) Cut to "Hold" at Leerink PartnrsLeerink Partnrs lowered shares of Arvinas from a "strong-buy" rating to a "hold" rating in a research report on Sunday.June 3, 2025 | marketbeat.comLeerink Partners Downgrades Arvinas (ARVN)June 3, 2025 | msn.comArvinas-Pfizer partnership dynamics may shift, says H.C. WainwrightJune 2, 2025 | msn.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Arvinas, Inc. - ARVNJune 2, 2025 | globenewswire.comArvinas and Pfizer Announce Phase 3 VERITAC-2 Trial Results Showing Vepdegestrant Improves Progression-Free Survival in ESR1-Mutant Breast Cancer PatientsJune 2, 2025 | nasdaq.comArvinas Shares Sink After Breast Cancer Treatment Didn't Improve Survival in Intent-to-Treat PopulationJune 2, 2025 | marketwatch.comArvinas (NASDAQ:ARVN) Earns Market Perform Rating from Leerink PartnersLeerink Partners reaffirmed a "market perform" rating and issued a $9.00 price objective (down from $10.00) on shares of Arvinas in a research note on Monday.June 2, 2025 | marketbeat.comBank of America Corp DE Sells 350,298 Shares of Arvinas, Inc. (NASDAQ:ARVN)Bank of America Corp DE trimmed its position in shares of Arvinas, Inc. (NASDAQ:ARVN - Free Report) by 73.1% during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 128,755 shares of the company's stock after selling 350,298June 2, 2025 | marketbeat.comArvinas Stock Price HistoryJune 1, 2025 | investing.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Arvinas, Inc. ...June 1, 2025 | gurufocus.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Arvinas, Inc. - ARVNJune 1, 2025 | prnewswire.comArvinas (NASDAQ:ARVN) Shares Down 4.7% - What's Next?Arvinas (NASDAQ:ARVN) Shares Down 4.7% - What's Next?May 31, 2025 | marketbeat.comPfizer-Arvinas breast cancer drug tops AstraZeneca's in delaying progressionMay 31, 2025 | reuters.comArvinas and Pfizer's Vepdegestrant Significantly Improves Progression-Free Survival for Patients with ESR1-Mutant, ER+/HER2- Advanced Breast CancerMay 31, 2025 | globenewswire.comVoloridge Investment Management LLC Makes New Investment in Arvinas, Inc. (NASDAQ:ARVN)Voloridge Investment Management LLC acquired a new stake in shares of Arvinas, Inc. (NASDAQ:ARVN - Free Report) in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor acquired 39,063 shares of the compMay 31, 2025 | marketbeat.comArvinas to Present at Jefferies Global Healthcare ConferenceMay 30, 2025 | globenewswire.comArvinas (NASDAQ:ARVN) Trading 7.9% Higher - What's Next?Arvinas (NASDAQ:ARVN) Trading 7.9% Higher - Here's WhyMay 29, 2025 | marketbeat.comKirby McInerney LLP is Investigating Potential Shareholder Claims Against Arvinas, Inc. (ARVN)May 28, 2025 | businesswire.comTwo Sigma Advisers LP Raises Holdings in Arvinas, Inc. (NASDAQ:ARVN)Two Sigma Advisers LP raised its stake in Arvinas, Inc. (NASDAQ:ARVN - Free Report) by 24.2% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 282,600 shares of the company's stock after purchasingMay 27, 2025 | marketbeat.comArvinas, Inc. (NASDAQ:ARVN) Receives Consensus Recommendation of "Moderate Buy" from BrokeragesShares of Arvinas, Inc. (NASDAQ:ARVN - Get Free Report) have been given an average rating of "Moderate Buy" by the twenty ratings firms that are currently covering the company, Marketbeat.com reports. Eight research analysts have rated the stock with a hold rating and twelve have assigned a buy raMay 27, 2025 | marketbeat.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Arvinas, Inc. ...May 26, 2025 | gurufocus.comWoodline Partners LP Has $13.28 Million Stock Holdings in Arvinas, Inc. (NASDAQ:ARVN)Woodline Partners LP lifted its stake in shares of Arvinas, Inc. (NASDAQ:ARVN - Free Report) by 39.2% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 692,733 shares of the company's stock after purchasing an additionalMay 24, 2025 | marketbeat.comBragar Eagel & Squire, P.C. Is Investigating Organon, Landstar, Arvinas, and GoHealth and Encourages Investors to Contact the FirmMay 23, 2025 | morningstar.comTwinbeech Capital LP Invests $3.15 Million in Arvinas, Inc. (NASDAQ:ARVN)Twinbeech Capital LP purchased a new position in shares of Arvinas, Inc. (NASDAQ:ARVN - Free Report) in the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor purchased 164,112 shares of the company's stock,May 23, 2025 | marketbeat.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Arvinas, Inc. - ARVNMay 20, 2025 | prnewswire.comNorthern Trust Corp Purchases 42,638 Shares of Arvinas, Inc. (NASDAQ:ARVN)Northern Trust Corp boosted its stake in shares of Arvinas, Inc. (NASDAQ:ARVN - Free Report) by 7.2% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 631,131 shares of the company's stock after buyingMay 19, 2025 | marketbeat.comArvinas Inc.May 18, 2025 | marketwatch.comRTW Investments LP Grows Stake in Arvinas, Inc. (NASDAQ:ARVN)RTW Investments LP boosted its position in Arvinas, Inc. (NASDAQ:ARVN - Free Report) by 19.8% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 3,334,308 shares of the company's stock after purchasing an addiMay 18, 2025 | marketbeat.comPatient Square Capital LP Makes New $1.66 Million Investment in Arvinas, Inc. (NASDAQ:ARVN)Patient Square Capital LP acquired a new position in shares of Arvinas, Inc. (NASDAQ:ARVN - Free Report) in the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor acquired 86,627 shares of the company's stock, valued at approximately $1,661,000. Arvinas mMay 16, 2025 | marketbeat.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Arvinas, Inc. - ARVNMay 13, 2025 | globenewswire.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Arvinas, Inc. ...May 12, 2025 | gurufocus.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Arvinas, Inc. - ARVNMay 12, 2025 | prnewswire.comDimensional Fund Advisors LP Raises Position in Arvinas, Inc. (NASDAQ:ARVN)Dimensional Fund Advisors LP boosted its position in Arvinas, Inc. (NASDAQ:ARVN - Free Report) by 28.3% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 843,430 shares of the company's stock after purchasing aMay 11, 2025 | marketbeat.comFY2025 EPS Estimates for Arvinas Raised by Cantor FitzgeraldArvinas, Inc. (NASDAQ:ARVN - Free Report) - Stock analysts at Cantor Fitzgerald raised their FY2025 EPS estimates for Arvinas in a research report issued to clients and investors on Tuesday, May 6th. Cantor Fitzgerald analyst L. Watsek now expects that the company will post earnings of ($0.56) peMay 10, 2025 | marketbeat.comAlgert Global LLC Has $3.95 Million Stake in Arvinas, Inc. (NASDAQ:ARVN)Algert Global LLC lifted its stake in shares of Arvinas, Inc. (NASDAQ:ARVN - Free Report) by 22.6% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 205,988 shares of the company's stock after acquiring an additional 37,927May 9, 2025 | marketbeat.comCitigroup Cuts Arvinas (NASDAQ:ARVN) Price Target to $9.50Citigroup lowered their target price on shares of Arvinas from $10.00 to $9.50 and set a "neutral" rating for the company in a research note on Monday.May 7, 2025 | marketbeat.com Get Arvinas News Delivered to You Automatically Sign up to receive the latest news and ratings for ARVN and its competitors with MarketBeat's FREE daily newsletter. Email Address ARVN Media Mentions By Week ARVN Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ARVN News Sentiment▼0.670.90▲Average Medical News Sentiment ARVN News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ARVN Articles This Week▼187▲ARVN Articles Average Week Get Arvinas News Delivered to You Automatically Sign up to receive the latest news and ratings for ARVN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies NAMS News Today KNSA News Today VCEL News Today RXRX News Today DNLI News Today CGON News Today HRMY News Today TWST News Today BLTE News Today AGIO News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ARVN) was last updated on 6/12/2025 by MarketBeat.com Staff From Our PartnersTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredMarch 16th -- America’s most important day?50-Year Legend: Here's The Day Stocks Likely Crash Legendary quant analyst Marc Chaikin says in 50 years on...Chaikin Analytics | SponsoredBillionaires are piling into this gold investmentBillionaires Are Piling into a Special Gold Investment With record gold prices, everyday Americans are scra...Weiss Ratings | SponsoredBig Changes Coming to Social Security?According to legendary investor Louis Navellier... This new Trump move could soon not only save Social Secu...InvestorPlace | SponsoredSHOCKING: Musk's Pentagon Secret Mission...It's about a harrowing message discovered on December 16, 2024: "美国军方暗杀名单" It's the reason President Tru...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Arvinas, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Arvinas With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
